Included in the formulation
АТХ:N.03.A.X Other antiepileptic drugs
Pharmacodynamics:Has anticonvulsant, psycho-stimulating and vasodilating action, caused by the effects of medicinal products that make up its composition.
Pharmacokinetics:Not studied.
Contraindications:Individual intolerance, including bromide preparations; Pacute / hepatic insufficiency.
Pregnancy and lactation:Category of recommendations Food and Drug Administration (US Food and Drug Administration) not determined. Adequate and well-controlled studies in humans have not been conducted. Not recommended during pregnancy and during breastfeeding.
Dosing and Administration:Inside, after eating, 2-4 tablets 2-3 times a day. The maximum dose for children under 10 years is 5 tablets per day.
Side effects:Violation of gait; fromoneness; retardation; rash.
Overdose:Symptoms: increased severity of side effects. Treatment: gastric lavage, reception of activated charcoal, symptomatic therapy.
Interaction:The action of phenobarbital (in the combination "brominated + calcium gluconate + caffeine + papaverine + phenobarbital ") increases when combined with amitriptyline, diazepam, chlordiazepoxide.
Acetazolamide reduces the reabsorption of phenobarbital in the kidneys, which leads to a weakening of its action.
The drug reduces the antifungal effect of griseofulvin with simultaneous use.
The combination "brominated + calcium gluconate + caffeine + papaverine + phenobarbital "reduces the blood content of doxycycline.
Simultaneous use of the drug with phenytoin leads to increase the content of phenobarbital in the blood serum.
Special instructions:Patients with minor hypercalciuria, decreased glomerular filtration, or with nephrolithiasis in the history of the drug should be administered under the control of calcium in the urine. Against the background of taking the drug, alcohol is not recommended.During treatment should refrain from performing work that requires speed of psychomotor reactions (including driving).